Search for: [Abstract = "Borderline ovarian tumors \(BOT\) are heterogeneous group of epithelial tumors with some unclear malignant potential, but without stroma invasion.The incidence of BOT varies between 12\-15% of epithelial ovarian tumors \(both BOT and ovarian carcinomas\). Over the last fifty years the interest has increased from 5% to 25% of epithelial ovarian tumors. In contrary to ovarian cancers BOT are diagnosed 10 years earlier \(45th vs. 55th year of life\) and carry a good prognosis. Long\-term overall survival \(OS\) in case of stage I FIGO \(Fédération Internationale de Gynécologie et d'Obstétrique\) is nearly 100% and in all stages of the disease around 95 \- 97%. The basic treatment is surgery. Due to a very good prognosis it is important to know the potential side effects of the treatment options when deciding about the management.The aim of the study was the assessment of treatment outcomes, prognostic factors, quality of life \(QoL\) and fertility after conserving treatment of the patients’ population with BOT treated in Department of Gynecology and Oncology, University Hospital in Krakow.Basing on the available literature and our results predictive factors in terms of optimal treatment strategies for BOT were suggested. The diagnostic and treatment algorithm for BOT was presented.96 Patients treated due to BOT between years 2000 and 2012 were included into the study. The median age was 48 years"]
